In such cases, second line therapeutics typically consist of biologic DMARDs designed to modulate specific cellular and molecular inflammatory pathways, targeting B cells (anti-CD20 rituximab), pro-inflammatory cytokines (tumor necrosis factor [TNF]- adalimumab) or its receptors (interleukin-6 receptor [IL-6R] tocilizumab), among others (66)
Are there reasons to avoid B12 injections
If denied, appeal using documented comorbidities and previous weight-loss efforts
In the lean stack protocol , it functions as the metabolic regulator by: Activating GLP-1 receptors to suppress appetite and slow gastric emptying Activating GIP receptors to enhance insulin sensitivity in adipose tissue Activating glucagon receptors to increase energy expenditure and fat oxidation Reducing body weight through combined anorectic and thermogenic effects Improving glycaemic control in metabolic research models Retatrutide has demonstrated the most significant weight reduction of any incretin-based compound in Phase 2 clinical data, with mean reductions of 24.2% over 48 weeks at the highest dose making it the centrepiece of the lean stack protocol
In a preclinical study, Stattic, a small molecular STAT3 blocker, alleviated nephritis in lupus prone MRL/lpr mice (58, 63)
